Ionomycin-induced mouse oocyte activation can disrupt preimplantation embryo development through increased reactive oxygen species reaction and DNA damage.
Animals
Calcium Signaling
/ drug effects
Cells, Cultured
DNA Damage
/ physiology
Embryo, Mammalian
Embryonic Development
/ drug effects
Female
Fertilization
/ drug effects
In Vitro Oocyte Maturation Techniques
/ methods
Ionomycin
/ pharmacology
Male
Mice
Mice, Inbred C57BL
Oocytes
/ drug effects
Reactive Oxygen Species
/ metabolism
DNA
ROS
artificial oocyte activation
damage
embryonic development
ionomycin
Journal
Molecular human reproduction
ISSN: 1460-2407
Titre abrégé: Mol Hum Reprod
Pays: England
ID NLM: 9513710
Informations de publication
Date de publication:
01 10 2020
01 10 2020
Historique:
received:
21
02
2020
revised:
01
07
2020
pubmed:
23
7
2020
medline:
27
8
2021
entrez:
23
7
2020
Statut:
ppublish
Résumé
Oocyte activation induced by calcium oscillations is an important process in normal fertilization and subsequent embryogenesis. In the clinical-assisted reproduction, artificial oocyte activation (AOA) is an effective method to improve the clinical outcome of patients with null or low fertilization rate after ICSI. However, little is known about the effect of AOA on preimplantation embryo development in cases with normal fertilization by ICSI. Here, we used ionomycin at different concentrations to activate oocytes after ICSI with normal sperm and evaluated energy metabolism and preimplantation embryo development. We found that a high concentration of ionomycin increased the frequency and amplitude of calcium oscillation patterns, affecting the balance of mitochondrial energy metabolism, leading to increased reactive oxygen species (ROS) and decreased ATP. Eventually, it increases DNA damage and decreases blastocyst formation. In addition, the addition of vitamin C to the culture medium ameliorated the increase in ROS and DNA damage and rescued the abnormal embryo development caused by excessive ionomycin activation. This study provides a perspective that the improper application of AOA may have adverse effects on preimplantation embryo development. Thus, clinical AOA treatment should be cautiously administered.
Identifiants
pubmed: 32697831
pii: 5875064
doi: 10.1093/molehr/gaaa056
doi:
Substances chimiques
Reactive Oxygen Species
0
Ionomycin
56092-81-0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
773-783Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please email: journals.permissions@oup.com.